(Q51699074)

10 April 2018

title

Five-drug antiemetic combination for cisplatin chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1581829

11 October 2022

author name string

K. S. Sridhar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1581829

11 October 2022

A. M. Hussein

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1581829

11 October 2022

S. Hilsenbeck

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1581829

11 October 2022

V. Cairns

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1581829

11 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1581829

11 October 2022

publication date

1 January 1992

1 reference

10 April 2018

published in

Cancer Investigation

1 reference

10 April 2018

volume

10

1 reference

10 April 2018

issue

3

1 reference

10 April 2018

page(s)

191-199

1 reference

10 April 2018

Cancer Treatment Needs Better Antiemetics

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032760

Doxorubicin plus cisplatin in the treatment of apudomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032760

A comparison of the antiemetic effects of droperidol and prochlorperazine in chemotheray with cis-platinum

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032760

Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032760

Cis-diamminedichloroplatinum (II). A new anticancer drug

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032760

Combination antiemetics for cisplatin chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032760

Allergic reaction to 5-fluorouracil infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032760

Drug therapy. Metoclopramide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032760

The control of chemotherapy-induced emesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032760

Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone versus high-dose metoclopramide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032760

Combination antiemetic therapy in cisplatin-induced nausea and vomiting.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032760

Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032760

Antiemetic efficacy of high-dose dexamethasone: randomized, double-blind, crossover study with a combination of dexamethasone, metoclopramide and diphenhydramine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032760

Antiemetic control and prevention of side effects of anti-cancer therapy with lorazepam or diphenhydramine when used in combination with metoclopramide plus dexamethasone. A double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032760

Double-blind randomized cross-over trial of dexamethasone and prochlorperazine as anti-emetics for cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032760

Oral metoclopramide with or without diphenhydramine: potential for prevention of late nausea and vomiting induced by cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032760

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032760

Lorazepam in cancer patients treated with cisplatin: a drug having antiemetic, amnesic, and anxiolytic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032760

Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032760

Delta-9-Tetrahydrocannabinol in Cancer Chemotherapy: Research Problems and Issues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032760

Dose ranging phase I study of the serotonin antagonist GR38032F for prevention of cisplatin-induced nausea and vomiting

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032760

The serotonin type 3 receptor antagonist BRL 43694 and nausea and vomiting induced by cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032760

10.3109/07357909209032760

21 January 2018

Identifiers

DOI

1 reference

10 April 2018

1 reference

10 April 2018